Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07756242 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Pharmacokinetic Study of Therapeutic Plasma Exchange

StatusWithdrawn
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Withdrawn before enrolling Sponsor's reason: IRB Withdrew Study Due to Study Design Change Show 5 more changesShow less
    • Enrollment target: estimated 15 to confirmed 0
    • Primary endpoints: details revised at 1 of 1 entry
    • Eligibility criteria expanded, about 14 words
    • Secondary endpoints: details revised at 1 of 1 entry
    • Site contact updated
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to characterize the pharmacokinetics of one or more ICIs during and after TPE/PLEX in patients with severe irAEs.
Trial Details
NCT Number NCT07756242
Lead Sponsor University of Chicago
Conditions
(from sponsor)		 Immune-related Adverse Event
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov